FDA — authorised 2 August 1976
- Application: NDA017078
- Marketing authorisation holder: IMPAX LABS INC
- Status: supplemented
FDA authorised Dexedrine on 2 August 1976
Yes. FDA authorised it on 2 August 1976; FDA has authorised it.
IMPAX LABS INC holds the US marketing authorisation.